Related references
Note: Only part of the references are listed.Diaphragma juglandis extracts modifies the gut microbiota during prevention of type 2 diabetes in rats
Feng Zhang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Metabolomics analysis of human plasma reveals decreased production of trimethylamine N-oxide retards the progression of chronic kidney disease
Da-Yong Hu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Multi-omics reveals that Bifidobacterium breve M-16V may alleviate the immune dysregulation caused by nanopolystyrene
Na Li et al.
ENVIRONMENT INTERNATIONAL (2022)
Pharmacological targeting macrophage phenotype via gut-kidney axis ameliorates renal fibrosis in mice
Yanan Xie et al.
PHARMACOLOGICAL RESEARCH (2022)
Integrated metagenomics identifies a crucial role for trimethylamine-producing Lachnoclostridium in promoting atherosclerosis
Yuan-Yuan Cai et al.
NPJ BIOFILMS AND MICROBIOMES (2022)
Yellow Wine Polyphenolic Compound Protects Against Doxorubicin-Induced Cardiotoxicity by Modulating the Composition and Metabolic Function of the Gut Microbiota
Hui Lin et al.
CIRCULATION-HEART FAILURE (2021)
Protection Mechanisms Underlying Oral Administration of Chlorogenic Acid against Cadmium-Induced Hepatorenal Injury Related to Regulating Intestinal Flora Balance
Yixin Ding et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
Chlorogenic Acid Alleviates Hyperglycemia-Induced Cardiac Fibrosis through Activation of the NO/cGMP/PKG Pathway in Cardiac Fibroblasts
Linhui Qin et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2021)
The Fibrotic Effects of TMAO on Human Renal Fibroblasts Is Mediated by NLRP3, Caspase-1 and the PERK/Akt/mTOR Pathway
Stefania Kapetanaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice
Wenchao Zhang et al.
SCIENTIFIC REPORTS (2021)
The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease
Han Zhu et al.
CELL METABOLISM (2021)
Lactobacillus rhamnosus LRa05 Ameliorate Hyperglycemia through a Regulating Glucagon-Mediated Signaling Pathway and Gut Microbiota in Type 2 Diabetic Mice
Tao Wu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
Fisetin Improves Hyperuricemia-Induced Chronic Kidney Disease via Regulating Gut Microbiota-Mediated Tryptophan Metabolism and Aryl Hydrocarbon Receptor Activation
Qian Ren et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
Limosilactobacillus fermentum JL-3 isolated from Jiangshui ameliorates hyperuricemia by degrading uric acid
Ying Wu et al.
GUT MICROBES (2021)
Chlorogenic acid inhibits trimethylamine-N-oxide formation and remodels intestinal microbiota to alleviate liver dysfunction in high l-carnitine feeding mice
Xiangnan Zhang et al.
FOOD & FUNCTION (2021)
Chlorogenic acid supplementation ameliorates hyperuricemia, relieves renal inflammation, and modulates intestinal homeostasis
Xiaofei Zhou et al.
FOOD & FUNCTION (2021)
Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia
Libin Pan et al.
ACTA PHARMACEUTICA SINICA B (2020)
Protective effects of tuna meat oligopeptides (TMOP) supplementation on hyperuricemia and associated renal inflammation mediated by gut microbiota
Jiaojiao Han et al.
FASEB JOURNAL (2020)
MFAP4 deficiency alleviates renal fibrosis through inhibition of NF-κB and TGF-β/Smad signaling pathways
Zhou Pan et al.
FASEB JOURNAL (2020)
Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy
Yingfeng Shi et al.
CELL DEATH & DISEASE (2020)
Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy
Min Shi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Naringin Attenuates High Fat Diet Induced Non-alcoholic Fatty Liver Disease and Gut Bacterial Dysbiosis in Mice
Hongna Mu et al.
FRONTIERS IN MICROBIOLOGY (2020)
Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease
Ya-Long Feng et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Oolong Tea Extract and Citrus Peel Polymethoxyflavones Reduce Transformation of L-Carnitine to Trimethylamine-N-Oxide and Decrease Vascular Inflammation in L-Carnitine Feeding Mice
Pei-Yu Chen et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD
Yuka Sato et al.
NATURE REVIEWS NEPHROLOGY (2019)
Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-kappa B pathways
Liping Bao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells
Maria Grazia Refolo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Effect of coffee or coffee components on gut microbiome and short-chain fatty acids in a mouse model of metabolic syndrome
Kazuchika Nishitsuji et al.
SCIENTIFIC REPORTS (2018)
Alterations of the Gut Microbiome Associated With the Treatment o f Hyperuricaemia in Male Rats
Yiran Yu et al.
FRONTIERS IN MICROBIOLOGY (2018)
Chlorogenic Acid Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting TLR4/NF-κB Signal Pathway
Han-Yang Ye et al.
INFLAMMATION (2017)
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients
Kai-Yu Xu et al.
SCIENTIFIC REPORTS (2017)
Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps
Hamid Rabb et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress
Haitao Shi et al.
CLINICAL NUTRITION (2016)
Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors
Jennifer L. Pluznick
KIDNEY INTERNATIONAL (2016)
Intestinal Microbiota Distinguish Gout Patients from Healthy Humans
Zhuang Guo et al.
SCIENTIFIC REPORTS (2016)
Microbiology Meets Big Data: The Case of Gut Microbiota-Derived Trimethylamine
Gwen Falony et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 69 (2015)
EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy
Na Liu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Therapeutic targets for treating fibrotic kidney diseases
So-Young Lee et al.
TRANSLATIONAL RESEARCH (2015)
Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFκB/IL-1β signaling
M. Zhang et al.
CELL DEATH & DISEASE (2015)
Oxidative stress and autophagy: Crucial modulators of kidney injury
Angara Sureshbabu et al.
REDOX BIOLOGY (2015)
Gut-Microbiota-Metabolite Axis in Early Renal Function Decline
Clara Barrios et al.
PLOS ONE (2015)
The Gut as a Source of Inflammation in Chronic Kidney Disease
Wei Ling Lau et al.
NEPHRON (2015)
Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease
W. H. Wilson Tang et al.
CIRCULATION RESEARCH (2015)
Molecular Epidemiology of Enterococcal Bacteremia in Australia
Geoffrey W. Coombs et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Uric Acid as a Target of Therapy in CKD
Diana I. Jalal et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
PI3K signalling: the path to discovery and understanding
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
A role for uric acid in the progression of renal disease
DH Kang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Share Paper
